Constellation Brands to invest extra $4bn in cannabis company

Constellation Brands, the owner of Corona, Kim Crawford Wines and Ballast Point, is to increase its stake in Canadian cannabis company Canopy Growth, investing US$4 billion to acquire a 38% share of the business.

The drinks giant said that the deal would position Canopy Growth as “the global leader in cannabis production, branding, intellectual property and retailing”.

Constellation will acquire 104.5 million shares, priced at C$48.60 (US$37) per share, from Canopy Growth, increasing its stake in the business from 9.9% to 38%. 

The company acquired its initial stake in October last year for £141 million (US$179m), back when, according to the Wall Street Journal, Canopy Growth had a market value of £1.3 billion (US$1.6bn).

Following the release of its first quarter results, Constellation revealed that in spite of falling sales, its investment in Canopy Growth was already bearing fruit.

Speaking on a conference call in July, chief financial officer David Eric Klein said that Constellation won roughly $258 million in “pre-tax unrealised gain from the change in fair value of the Canopy Growth investment and warrants,” bringing its net gain up to $700 million.

The new deal, which it claims is “the largest to date in the cannabis space,” cements Canopy Growth as its exclusive global cannabis partner. Constellation said that the funds will enable Canopy Growth to “build and/or acquire key assets” in around 30 countries that are legally developing a medical cannabis programmes.

Following the deal, which is still subject to regulatory approval, Constellation will supply four directors to Canopy Growth’s board, chaired by Bruce Linton. Constellation will also receive 139.7 million new warrants which are exercisable over the next 3 years, and should it choose to exercise them, it would become a majority stakeholder in the cannabis company.

If granted approval, the deal is expected to be completed in October 2018.

Rob Sands, chief executive officer, Constellation Brands, said: “Through this investment, we are selecting Canopy Growth as our exclusive global cannabis partner.

“Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space. We look forward to supporting Canopy as they extend their recognised global leadership position in the medical and recreational cannabis space.”

Founded in 2013 and headquartered in Ontario, Canopy Growth already has a presence in 11 countries and specialises in production innovation and clinical research. In April 2014, it became the first cannabis company in North America to be publicly traded.

Bruce Linton, chairman and co-CEO of Canopy Growth, added: “Our business can now make the strategic investments required to accelerate our market position globally. Constellation’s concentration of global cannabis activities exclusively through Canopy, coupled with the investment and its expert capabilities in brand-building, marketing, consumer insights and M&A will be a huge benefit as we look to expand our portfolio in Canada, the United States and emerging cannabis markets around the globe. We view this investment in our business as an endorsement of our execution since forming our initial strategic relationship in October 2017”.

Since Constellation Brands’ initial investment last year, the cannabis sector has received considerable attention from drinks companies in spite of the laws and regulations that govern its use across the world.

Earlier this month, beer giant Molson Coors partnered with Canadian cannabis producer The Hydropothecary Corporation, to launch a standalone startup business to develop “non-alcoholic, cannabis-infused beverages for the Canadian market following legalisation”.

Last month, a team of Canadian scientists announced that they were attempting to make a beer brewed with the “stalks, stem and roots of the cannabis plant”.

Meanwhile, in May, the Canadian branch of distributor Southern Glazer’s Wine and Spirits created an off-shoot dedicated to cannabis products. It hatched a deal with marijuana producer Aphria to distribute its products across Canada when the drug is officially legalised later this year.

Among those planning to launch cannabis-related drinks products include Heineken-owned US craft brewer Lagunitas with its “IPA-inspired, THC-infused sparkling water,” a cannabis-infused Sauvignon Blanc from California’s Rebel Coast Winery and Blue Moon creator Keith Villa’s new business dedicated to producing cannabis-infused craft beer.

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our newsletters

Events Executive

67 Pall Mall
Pall Mall, London SW1Y 5ES, UK

Fine Wine Sales Executive

Roberson Wine
London, UK

Account Manager - London Trade Sales

Bancroft Wines Ltd
London, UK

Brand Manager

Elixir Distillers
Park Royal, London UK

Marketing Assistant

Speciality Brands
Park Royal, London, UK

Key Account Manager

MMI Maldives
Maldives

Financial Controller

London City Bond
Barking, UK

Duty Manager

The Whisky Exchange
Great Portland Street, London

Spirits Advisor

The Whisky Exchange
London, UK

International Sales Manager

Elixir Distillers
Park Royal, London, UK

Millésime Bio 2020

Montpellier,France
27th Jan 2020

Maisons Marques et Domaines Annual Tasting

London,United Kingdom
29th Jan 2020

Austrian Wine Tasting

London,United Kingdom
3rd Feb 2020
Click to view more